Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial

作者：Peter M Ellis, Frances Alice Shepherd, Michael J. Millward, Federica Perrone, Lesley Seymour, Geoffrey Liu, Sophie B. Sun, Byoung Chul Cho, Alessandro Morabito, Natasha B. Leighl, Martin R. Stockler, Christopher William Lee, Rafal F. Wierzbicki, Victor Cohen, Normand Blais, Randeep S. Sangha, Adolfo Gino Favaretto, Jin Hyoung Kang, Ming‐Sound Tsao, Carolyn F. Wilson, Zelanna Goldberg, Keyue Ding, Glenwood D. Goss, Penelope Ann Bradbury · 发表于：The Lancet Oncology · 年份：2014 · DOI：10.1016/s1470-2045(14)70472-3 · 被引用次数：132 · 研究领域：Lung Cancer Treatments and Mutations、Cancer Immunotherapy and Biomarkers、Lung Cancer Diagnosis and Treatment